Synthetic genomics: Options for governance

Industrial Biotechnology

Volumn 3, Issue 4, 2007, Pages 333-365

  Garfinkel, Michele S ^a   Endy, Drew ^b   Epstein, Gerald L ^c   Friedman, Robert M ^a  

^a J CRAIG VENTER INSTITUTE   (United States)

^b Architecture Machine Group

^c Science and Security in the CSIS Homeland Security Program

Author keywords

[No Author keywords available]

Indexed keywords

CONSTITUENT CHEMICALS; DUAL-USE CONCERNS; SYNTHETIC GENOMICS;

BIOFUELS; COMPUTATIONAL COMPLEXITY; DNA; DRUG PRODUCTS; GENETIC ENGINEERING;

GENES;

BIOFUELS; COMPUTATIONAL COMPLEXITY; DNA; DRUG PRODUCTS; GENES; GENETIC ENGINEERING;

EID: 38349008407     PISSN: 15509087     EISSN: None     Source Type: Journal    
DOI: 10.1089/ind.2007.3.333     Document Type: Review

References (76)

1. Atlas RM, Dando M. The dual-use dilemma for life sciences: Perspectives, conundrums, and global solutions. Biosecur Bioterror 4, 276-286 (2006)
2. Committee on Research Standards and Practices to Prevent the Destructive Application of Biotechnology, National Research Council of the National Academies. Biotechnology Research in an Age of Bioterrorism. National Academies Press, Washington, DC (2004).
3. Epstein GL. Controlling biological warfare threats: Resolving potential tensions among the research community, Industry, and the national security community. Crit Rev Microbiol 27:321-354 (2001)
4. Rogers M. The Pandora's Box congress. Rolling Stone, p. 37 (19 June 1975).
5. Amsellem Z, Cohen BA, Gressel J. Engineering hypervirulence in a mycoherbicidal fungus for efficient weed control. Nature Biotechnol 20, 1035-1039 (2002)
6. Tucker JB, Zilinskas RA. The promise and perils of synthetic biology. New Atlantis Spring 2006: 25-45 (2006)
7. United States Environmental Protection Agency. Toxic Substances Control Act. 15 USC s/s 2601 etseq (1976)
8. Cho MK, Magnus D, Caplan AL, McGee D, Ethics of Genomics Group. Ethical considerations in synthesizing a minimal genome. Science 286, 2087-2090 (1999)
9. Hutchison III CA, Peterson SN, Gill SR, Cline RT, White O, Fraser CM, Smith HO, Venter JC. Global transposon mutagenesis and a minimal mycoplasma genome. Science 286, 2165-2169 (1999)
10. Committee on Biological Threats to Agricultural Plants and Animals, National Research Council of the National Academies. Countering Agricultural Bioterrorism. National Academies Press, Washington, District of Columbia (2003)
11. Committee on Genomics Databases for Bioterrorism Threat Agents. National Research Council of the National Academies. Seeking Security: Pathogens, Open Access, and Genome Databases. National Academies Press. Washington, District of Columbia (2004)
12. Committee on Research Standards and Practices, op cit at 2.
13. Committee on Research Standards and Practices, op cit at 2.
14. National Science Advisory Board for Biosecurlty. Addressing Blosecurity Concerns Related to the Synthesis of Select Agents. http://www.biosecurityboard .gov/pdf/Final%20NSABB%20Report%20on%20Synthetic%20Genomics.pdf (2006)
15. National Science Advisory Board for Biosecurity. 2006. NSABB Draft Guidance Documents. http://www.biosecurityboard.gov/pdf/ NSABB%20Draft%20Guidance% 20Documents%2027Sep06%20(12%2011°/b202006).pdf
16. Church G. A Synthetic Biohazard Non-Proliferation Proposal. http://arep.med.harvard.edu/SBP/Church_Biohazard04c.doc (2004)
17. United States Department of Energy Biological and Environmental Research Advisory Committee. Synthetic Genomes: Technologies and Impact http://www.sc.doe.gov/ober/berac/SynBio.pdf (2004)
18. Maurer SM, Lucas KV, Terrell S. From Understanding to Action: Community-Based Options for Improving Safety and Security in Synthetic Biology. University of California, Berkeley. Draft 1.1. http://gspp. berkeley.edu/iths/UC%20White%20Paper.pdf (15 April 2006)
19. ETC Group (Action Group on Erosion, Technology, and Concentration). Extreme Genetic Engineering:An Introduction to Synthetic Biology. http://www.etcgroup.org/upload/publication/602/01/synbioreportweb.pdf (2007)
20. Conferees of the Second International Conference on Synthetic Biology. Declaration of the Second International Meeting on Synthetic Biology (Draft). http://hdl.handle.net/1721.1/32982 29 (May 2006)
21. Bügl H, Danner JP, Molinari RJ, Mulligan JT, Park H-O, Reichert B, Roth DA, Wagner R, Budowle B, Scripp RM, Smith JAL, Steele SJ, Church G, Endy D. DNA Synthesis and Biological Security. Nature Biotechnol 25, 627-629 (2007)
22. Cho et al op cit at 8
23. De Vriend H. Constructing Life. Early Social Reflections on the Emerging Field of Synthetic Biology (Working Document 97). Rathenau Institute, The Hague, http://www.lisconsult.nl/images/stories/Downloads/ wed97_constructing_life_2006.pdf (2006)
24. Convention on the Prohibition of the Development and Stockpiling of Bacteriological (Biological) and Toxin Weapons and on Their Destruction http://www.opbw.org/convention/btwcsps.html (December 2007)
25. Working Group on Governance Dilemmas In Bioterrorism Response. Leading During Bloattacks and Epidemics with the Public's Trust and Help. Biosecur Bioterror 2, 25-40 (2004)
26. National Institutes of Health. Strategic Plan, National Institute of Allergy and Infectious Diseases Biodefense Research, http://www3.niaid.nih.gov/ biodefense/research/strat_plan.htm (2007)
27. Public Law 109-417. http://www.hhs.gov/aspr/barda/index.html
28. Bio-Economic Research Associates. Genome Synthesis and Design Futures: Implications for the US Economy, http://www.bio-era.net/research/ GenomePurchaseForm.html (2007)
29. Szostak JW, Bartel DP, Luisi PL. Synthesizing life. Nature 409, 387-390 (2001)
30. Gibbs WW. Synthetic life. Sci Am 290, 74-81 (2005)
31. Chan et al, op cit at 28
32. Baric RS, Sheahan T, Deming D, Donaldson E, Yount B, Sims AC, Roberts RS, Frieman M, Rockx B. SARS Coronavirus vaccine development. Adv Exp Med Biol 581:553-60 (2006)
33. Department of Energy, op cit at 17
34. Ro DK, Paradise EM, Ouellet M, Fisher KJ, Newman KL, Ndungu JM, Ho KA, Eachus RA, Ham TS, Kirby J, Chang MC, Witheres ST, Shiba Y, Sarpong R, Keasling JD. Production of the antimalarial drug precursor artemisinic acid in engineered yeast. Nature 440: 852-853 (2006)
35. Kodumal SJ, Patel KG, Reid R, Menzella HG, Welch M, Santi DV. Total synthesis of long DNA sequences: Synthesis of a contiguous 32-kb polyketide synthase gene cluster. PNAS USA 101, 15573-15578 (2004)
36. Herper M. The biggest DNA ever made. Forbes.com http://www.forbes.com /home/sclencesandmediclne/2006/07/12/dna-artiflcial-genes- codon-cz_ mh_0713codon.html (13 July 2006)
37. US Department of Energy, op cit at 34
38. Lynd LR, van Zyl WH, McBride JE, Laser M. Consolidated bloprocessing of cellulosic biomass: An update. Curr Opin Biotechnol 16: 577-583 (2005)
39. Department of Energy. Genomics:GTL BioenergyResearch Centers, Section 4. http://genomicsgtl.energy.gov/centers/GTLbiofuelscompendium.pdf (2006)
40. Aldor IS, Keasling JD. Process design for microbial plastic factories: Metabolic engineering of polyhydroxyalkanoates. CurrOpin Biotechnol 14, 475-483 (2003)
41. Biotechnology Industry Organization. New Biotech Tools for a Cleaner Environment, http://bio.org/ind/pubs/cleaner2004 (2004/2005)
42. Collett MS. Impact of Synthetic Genomics in the Threat of Bioterrorism with Viral Agents (this project; 2006)
43. Baric R. Synthetic Viral Genomics (this project; 2006)
44. American Type Culture Collection/ATCC. Manassas Virginia, http://www.atcc.org/common/cultures/Products.cfm
45. Centers for Disease Control and Prevention. HHS and USDA Select Agents and Toxins. http://www.cdc.gov/od/sap/docs/salist.pdf
46. Pewe L, Zhou H, Netland J, Tangudu C, Olivares H, Shi L, Look D, Gallagher T, Perlman S. 2005. A severe acute respiratory syndrome-associated coronavirus-specific protein enhances virulence of an attenuated murine Coronavirus. J Virol79, 11335-11342 (2005)
47. Ball P. Synthetic biology: Starting from scratch. Nature 431, 624-626 (2004)
48. Rogers M. The Pandora's Box congress. Rolling Stone, p. 37 and ff (19 June 1975)
49. Tumpey TM, Basler CF, Aguilar FV, Zeng H, Solorzano A, Swayne DE, Cox NJ, Katz JM, Taubenberger JK, Palese P, Garcia-Sastre A. Characterization of reconstructed 1918 Spanish influenza pandemic virus. Science 310, 77-80 (2005)
50. Aldhous P. The bioweapon is in the post. New Sci (9 November 2005)
51. Church, op cit at 16
52. National Science Advisory Board for Biosecurity, op cit at 14 53. Bügl et al., op cit at 38
53. Conferees of the Second International Meeting on Synthetic Biology, op cit at 20.
54. Jones R. Sequence Screening, http://www.craic.com (2005)
55. National Science Advisory Board for Biosecurity, op cit at 14
56. Sanghvi Y. A Roadmap to the Assembly of Synthetic DNA from Raw Materials (this project; 2005)
57. Lausted C, Dahl T, Warren C, King K, Smith K, Johnson M, Saleem R, Aitchison J, Hood L, Lasky SR. POSaM: A fast, flexible, open-source, inkjet oligonucleotide synthesizer and microarrayer. Genome Biol 5: R58. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid-507883 (2004)
58. Blaine J. Assessment of individuals requesting access to select agents. E-mail response dated 9/24/2007 from James Blaine, Deputy Director Division of Select Agents Program, Centers for Disease Control and Prevention, to author GL Epstein's request for information (2007)
59. Committee on Research Standards and Practices, op cit at 2
60. International Genetically Engineered Machine Competition. http://www.igem2006.com
61. National Institutes of Health NIH Guidelines for Research Involving Recombinant DNA Molecules (2002)
62. Centers for Disease Control and Prevention. Biosafety in Microbiological and Biomedical Laboratories, 4th ed. (1999)
63. World Health Organization. Biorisk Management:Laboratory Biosecurity Guidance, WHO/CDS/EPR/2006.6. Geneva, Switzerland (September 2006)
64. National Fire Protection Association, http://www.nfpa.org (2006)
65. University of Chicago. University Research Administration: Research Compliance[2005)
66. American Whitewater. Safety Program. http://www. americanwhitewater.org/content/Safety_view_ (2007)
67. Committee on Research Standards and Practices, op cit at 2
68. Committee on Research Standards and Practices, op cit at 2
69. Sunshine Project. Bioweapons infections hit Texas A&M University again. http://www.sunshine-project.org/publications/pr/pr260607.html
70. National Science Advisory Board for Blosecurity. Proposed Framework for the Oversight of Dual Use Life Science Research: Strategies for Minimizing the Potential Misuse of Research Information, http://www.biosecurityboard. gov/ Framework%20for%20transmittal%200807_Sept07.pdf (2007)
71. Schnirring L CDC suspends work at Texas A&M biodefense lab. CIDRAP News http://www.cidrap.umn.edu/cidrap/content/bt/bioprep/news/ jul0307bloweapons.html (2007)
72. Journal Editors and Authors Group. Statement on scientific publication and national security. Science299, 1149. http://www.sciencemag.org/ feature/data/ security/statement.pdf (2003)
73. Ibid
74. Committee on Research Standards and Practices, op cit at 2
75. National Science Advisory Board for Biosecurity, op cit at 72
76. Committee on Genomics Databases for Bioterrorism Threat Agents, National Research Council. Seeking Security: Pathogens, Open Access, and Genome Databases. National Academies Press, Washington, DC, p. 7(2004)